AOP Health’s First-in-class Investigational Cancer Drug Enters Phase 1 Trial
AOP Orphan Pharmaceuticals GmbH (AOP Health), in collaboration with Leukos Biotech, has reached a significant milestone in cancer therapy. The
Read moreAOP Orphan Pharmaceuticals GmbH (AOP Health), in collaboration with Leukos Biotech, has reached a significant milestone in cancer therapy. The
Read moreAI firm Generate:Biomedicines announced on Tuesday that it has secured a $1B+ collaboration with Novartis to advance AI-driven protein therapeutics.
Read moreThrough the strategic acquisition of Eli Lilly’s San Diego ‘Life Science Studio’, Arctoris’ has doubled the size of its existing
Read moreGoogle DeepMind has introduced AlphaProteo, an advanced AI system designed to generate novel proteins that bind to specific molecular targets.
Read moreimusyn’s Dyemer & myDyemer are a pioneering class of ready-to-use and loadable T Cell staining reagents, developed for precise quantification
Read moreResearchers have devised a novel human 3D model for Alzheimer’s Disease, enabling the study of immune cell involvement in the
Read moreCellendes has developed a ready-to-use 3-D Life ToGro Hydrogel Kit designed to enable 3D cell culture cultivation of most cells
Read moreThe Hamburg headquartered publicly listed drug discovery and development company Evotec and Variant Bio, a US-based biotech company leveraging the
Read morePreclinical data shows that Nutcracker’s mRNA drug candidate NTX-470 effectively targets CD3 T cells, demonstrating selective engagement with minimal unintended
Read moreAdvanced single-cell technologies, particularly methods such as single-cell RNA sequencing (scRNA-seq), coupled with sophisticated computational tools and the increasing accessibility
Read more